|
For Immediate Release: July 17, 2007
MDA Secures Role On Preparations For European Mars Rover Mission
Richmond, B.C. - MacDonald, Dettwiler and Associates Ltd. (TSX: MDA), a provider of essential information solutions,announced
today that it has been awarded a contract for €1M with EADS Astrium (UK), to provide
an advanced technology solution for ExoMars, the upcoming Mars mission of the European
Space Agency (ESA). MDA will design a robotic chassis for the ExoMars rover, and
provide a prototype solution for testing at ESA in 2008.
Dr. Paul Cooper, vice president and general manager of MDA's Brampton operations
stated, "The rover is a high profile element within ESA's ExoMars mission, and this
contract reaffirms the strategic relevance of our advanced technology solutions
to space exploration missions around the world. This phase of the contract continues
the work previously carried out by MDA on the earlier design phases of the ExoMars
mission."
About MDA
MDA provides advanced information solutions that capture and process vast amounts
of data, produce essential information, and improve the decision making and operational
performance of business and government organizations worldwide.
Focused on markets and customers with strong repeat business potential, MDA delivers
a broad spectrum of earth and space based information solutions, ranging from complex
operational systems, to tailored information services, to electronic information
products.
MDA employs more than 3,000 people in locations across the United States, the United
Kingdom, and Canada. The Company's common shares trade on the Toronto Stock Exchange
under the symbol TSX:MDA.
Related Websites:
www.mdacorporation.com
Forward Looking Statement
This release contains forward-looking statements and information, which
reflect the current view of MacDonald, Dettwiler and Associates Ltd. with respect
to future events and financial performance. Any such forward-looking statements
are subject to risks and uncertainties and MDA's actual results of operations could
differ materially from historical results or current expectations. Additional information
on these and other potential factors that could affect MDA's financial results are
detailed in documents filed from time to time with the applicable Canadian securities
regulatory authorities.
The Toronto Stock Exchange has neither approved nor disapproved the form or
content of this release.
|